303 related articles for article (PubMed ID: 21347512)
1. Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment.
Jeong JK; Moon MH; Seol JW; Seo JS; Lee YJ; Park SY
Int J Mol Med; 2011 May; 27(5):689-93. PubMed ID: 21347512
[TBL] [Abstract][Full Text] [Related]
2. Cellular cholesterol enrichment prevents prion peptide-induced neuron cell damages.
Jeong JK; Seol JW; Moon MH; Seo JS; Lee YJ; Kim JS; Park SY
Biochem Biophys Res Commun; 2010 Oct; 401(4):516-20. PubMed ID: 20875400
[TBL] [Abstract][Full Text] [Related]
3. Bee venom phospholipase A2 prevents prion peptide induced-cell death in neuronal cells.
Jeong JK; Moon MH; Bae BC; Lee YJ; Seol JW; Park SY
Int J Mol Med; 2011 Nov; 28(5):867-73. PubMed ID: 21701769
[TBL] [Abstract][Full Text] [Related]
4. Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.
Jeong JK; Moon MH; Lee YJ; Seol JW; Park SY
Int J Mol Med; 2012 Mar; 29(3):387-92. PubMed ID: 22179431
[TBL] [Abstract][Full Text] [Related]
5. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.
Kim BH; Lee HG; Choi JK; Kim JI; Choi EK; Carp RI; Kim YS
Brain Res Mol Brain Res; 2004 Apr; 124(1):40-50. PubMed ID: 15093684
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231.
Villa V; Corsaro A; Thellung S; Paludi D; Chiovitti K; Venezia V; Nizzari M; Russo C; Schettini G; Aceto A; Florio T
Ann N Y Acad Sci; 2006 Dec; 1090():276-91. PubMed ID: 17384271
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
[TBL] [Abstract][Full Text] [Related]
8. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection.
Carimalo J; Cronier S; Petit G; Peyrin JM; Boukhtouche F; Arbez N; Lemaigre-Dubreuil Y; Brugg B; Miquel MC
Eur J Neurosci; 2005 May; 21(9):2311-9. PubMed ID: 15932590
[TBL] [Abstract][Full Text] [Related]
9. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
11. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
12. The association between prion proteins and Aβ₁₋₄₂ oligomers in cytotoxicity and apoptosis.
Hyeon JW; Kim SY; Park JS; Choi BY; Lee SM; Ju YR; An SS; Kim CK
Biochem Biophys Res Commun; 2012 Jul; 424(2):214-20. PubMed ID: 22743555
[TBL] [Abstract][Full Text] [Related]
13. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
14. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein overexpression disturbs cellular homeostasis in SH-SY5Y neuroblastoma cells but does not alter p53 expression: a proteomic study.
Weiss E; Ramljak S; Asif AR; Ciesielczyk B; Schmitz M; Gawinecka J; Schulz-Schaeffer W; Behrens C; Zerr I
Neuroscience; 2010 Sep; 169(4):1640-50. PubMed ID: 20547212
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 protects against prion peptide-induced cell death in neuronal cells via inhibition of Bax translocation.
Park YG; Jeong JK; Moon MH; Lee JH; Lee YJ; Seol JW; Kim SJ; Kang SJ; Park SY
Int J Mol Med; 2012 Nov; 30(5):1069-74. PubMed ID: 22895829
[TBL] [Abstract][Full Text] [Related]
17. Microglia and prion disease: a review.
Brown DR; Kretzschmar HA
Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia.
Weise J; Doeppner TR; Müller T; Wrede A; Schulz-Schaeffer W; Zerr I; Witte OW; Bähr M
Restor Neurol Neurosci; 2008; 26(1):57-64. PubMed ID: 18431006
[TBL] [Abstract][Full Text] [Related]
19. Involvement of mitochondria in endoplasmic reticulum stress-induced apoptotic cell death pathway triggered by the prion peptide PrP(106-126).
Ferreiro E; Costa R; Marques S; Cardoso SM; Oliveira CR; Pereira CM
J Neurochem; 2008 Feb; 104(3):766-76. PubMed ID: 17995926
[TBL] [Abstract][Full Text] [Related]
20. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
